|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/385 | |
| A61K 47/54 | |||
| A61K 47/64 | |||
| A61P 31/00 | |||
| A61K 47/61 | |||
| C07K 7/62 |
| (11) | Patento numeris | 3512544 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17771531.5 |
| Europos patento paraiškos padavimo data | 2017-09-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-07-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-10-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2017/052699 |
| Data | 2017-09-13 |
| (87) | Numeris | WO 2018/051085 |
| Data | 2018-03-22 |
| (30) | Numeris | Data | Šalis |
| 201615560 | 2016-09-13 | GB | |
| 201707076 | 2017-05-04 | GB |
| (72) |
GLOSSOP, Melanie, GB
WATSON, Christine, GB
WESTBY, Michael, GB
|
| (73) |
Centauri Therapeutics Limited,
1st Floor Thavies Inn House 3-4 Holborn Circus, London EC1N 2HA,
GB
|
| (54) | PEPTIDE COMPOUNDS AND THERAPEUTIC USES THEREOF |
| PEPTIDE COMPOUNDS AND THERAPEUTIC USES THEREOF |